Key Takeaways Corcept reported Q3 EPS of $0.16, which missed estimates and fell from$0.41 in the prior-year quarter.CORT's revenues grew 14% year over year to $207.6 million in Q3 but missed expectations.CORT cut 2025 revenue guidance to$800-$850 million, prompting a 4.6% after-hours share drop.Corcept Therapeutics (CORT) reported third-quarter 2025 earnings of 16 cents per share, which missed the Zacks Consensus Estimate of 18 cents. The company had reported earnings of 41 cents per share in the year-ago ...